Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.

Sundar JagannathNedra JosephConcetta CriveraAkshay A KharatCarolyn C JacksonSatish ValluriPatricia CostHilary PhelpsRafal SlowikTimothy KleinLee SmolenXueting YuAdam D Cohen

Published in: Oncology and therapy (2023)

Cost estimates from this analysis, which disaggregates CAR-T therapy costs, provide a comprehensive view of the cost components of CAR-T therapy that can help healthcare decision-makers make informed choices regarding the use of cilta-cel. Real-world costs may differ with improved AE prevention and mitigation strategies.

Keyphrases

healthcare
multiple myeloma
stem cells
climate change
replacement therapy
cell therapy
smoking cessation